CaMKII in Sinus Node Physiology and Disease
CaMKII in Sinus Node Physiology and Disease
批准号:
9115686
负责人:
MARK E ANDERSON
金额:
$38.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-09 至 2017-12-31
关键词:
ATP Synthesis PathwayAmericanAngiotensin IIAnimal ModelApoptosisArrhythmiaArtificial cardiac pacemakerBoxingBradycardiaCardiomyopathiesCell DeathCell physiologyCellsCessation of lifeClinicalDataDiseaseDominant-Negative MutationFailureFeedbackFigs - dietaryFrequenciesFunctional disorderFundingGeneticHealthHealth BenefitHeart RateHeart failureHypertensionImplantInfectionInfusion proceduresLoxP-flanked alleleMechanicsMediatingMitochondriaModelingMorbidity - disease rateMusMuscle CellsMyocardialNatureNodalOperative Surgical ProceduresOxidative StressPacemakersPatientsPhosphorylationPhysiologicalPhysiologyPlayPublic HealthReactive Oxygen SpeciesReagentRegulationReninReportingRoleSarcoplasmic ReticulumSignal TransductionSinusStressSudden DeathTestingTherapeuticTimeTransgenic OrganismsUnited Statescalmodulin-dependent protein kinase IIfightinggenetic approachhigh riskimprovedin vivoinnovationmitochondrial permeability transition poremortalitymouse modelneglectnovelpreventresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): During the initial funding period, our group identified the multifunctional Ca2+ and calmodulin-dependent protein kinase II (CaMKII) as a necessary signal for physiological, 'fight or flight', increases in heart rate. We showed that the cellular mechanisms for CaMKII actions on heart rate were related to increasing sarcoplasmic reticulum Ca2+ leak but independent of the If 'pacemaker' current. We also found that excessive CaMKII activation contributed to sinoatrial nodal (SAN) dysfunction (SND) under conditions of increased oxidative stress, by increasing SAN cell apoptosis. SND causes symptomatic bradycardia and sudden death, particularly in patients and animal models with hypertension or heart failure, conditions marked by hyper-activation of the renin-angiotensin II (Ang II) signaling axis and elevated reactive oxygen species (ROS). Taken together, our studies show that CaMKII is important for physiological heart rate increases, but excessive CaMKII activity promotes SND. This dual role of CaMKII as a physiological and pathological signal has important parallels in myocardial physiology, where CaMKII may support the force-frequency response, and in disease, where excessive oxidized CaMKII (ox-CaMKII) contributes to cardiomyopathy and arrhythmias. We interpret emergent evidence in SAN to suggest that CaMKII inhibition slows heart rate, while protecting against excessive bradycardia due to SND in high risk clinical settings, modeled in mice by Ang II infusion. Our data suggest that CaMKII inhibition could eventually serve as a single, non-surgical therapy for regulating heart rate and preventing SND in high-risk patients. Our overall guiding hypothesis for this competitive renewal application is that CaMKII regulation of SAN mitochondria enhances physiological feedback to match energy demand with ATP synthesis and enable fight or flight heart rate increases, but excessive CaMKII activity results in mitochondrial Ca2+ overload that promotes SAN cell death and SND. We will test this innovative and novel mechanistic hypothesis using the following specific aims: Aim 1- Determine the role of mitochondrial CaMKII in SAN cell physiology and SND. Aim 2- Test the role of IMCU in SAN function and SND. Aim 3- Establish whether the MCU is a critical target for CaMKII effects on SAN physiology and SND.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CaMKII signaling in physiology, heart failure and arrhythmias
-
批准号:10335191
-
项目类别:
-
资助金额:$96.36万
-
财政年份:2018
-
负责人:MARK E ANDERSON
-
依托单位:
CaMKII signaling in physiology, heart failure and arrhythmias
-
批准号:10077577
-
项目类别:
-
资助金额:$119.86万
-
财政年份:2018
-
负责人:MARK E ANDERSON
-
依托单位:
CaMKII signaling in physiology, heart failure and arrhythmias
-
批准号:10026490
-
项目类别:
-
资助金额:$23.5万
-
财政年份:2018
-
负责人:MARK E ANDERSON
-
依托单位:
2014 Cardiac Regulatory Mechanisms Gordon Research Conference & Gordon Research S
-
批准号:8784793
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2014
-
负责人:MARK E ANDERSON
-
依托单位:
Mitochondrial Calmodulin Kinase II in Physiology and Disease
-
批准号:8909894
-
项目类别:
-
资助金额:$39.69万
-
财政年份:2014
-
负责人:MARK E ANDERSON
-
依托单位:
CaMKII in Sinus Node Physiology and Disease
-
批准号:8909874
-
项目类别:
-
资助金额:$39.53万
-
财政年份:2014
-
负责人:MARK E ANDERSON
-
依托单位:
CaMKII in Sinus Node Physiology and Disease
-
批准号:8915241
-
项目类别:
-
资助金额:$38.21万
-
财政年份:2014
-
负责人:MARK E ANDERSON
-
依托单位:
Mitochondrial Calmodulin Kinase II in Physiology and Disease
-
批准号:8915239
-
项目类别:
-
资助金额:$39.22万
-
财政年份:2014
-
负责人:MARK E ANDERSON
-
依托单位:
2012 Cardiac Regulatory Mechanisms Gordon Research Conference and Gordon Research
-
批准号:8316613
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2012
-
负责人:MARK E ANDERSON
-
依托单位:
Oxidized CaMKII in Atrial Fibrillation
-
批准号:8628170
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2012
-
负责人:MARK E ANDERSON
-
依托单位:
Oxidized CaMKII in Atrial Fibrillation
-
批准号:8812901
-
项目类别:
-
资助金额:$39.89万
-
财政年份:2012
-
负责人:MARK E ANDERSON
-
依托单位:
Oxidized CaMKII in Atrial Fibrillation
-
批准号:8271667
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2012
-
负责人:MARK E ANDERSON
-
依托单位:
Oxidized CaMKII in Atrial Fibrillation
-
批准号:8449636
-
项目类别:
-
资助金额:$35.94万
-
财政年份:2012
-
负责人:MARK E ANDERSON
-
依托单位:
CaMKII in Sinus Node Physiology and Disease
-
批准号:7695210
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:MARK E ANDERSON
-
依托单位:
CaMKII in Sinus Node Physiology and Disease
-
批准号:8575675
-
项目类别:
-
资助金额:$35.94万
-
财政年份:2009
-
负责人:MARK E ANDERSON
-
依托单位:
CaMKII in Sinus Node Physiology and Disease
-
批准号:8056075
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:MARK E ANDERSON
-
依托单位:
CaMKII in Sinus Node Physiology and Disease
-
批准号:8269846
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2009
-
负责人:MARK E ANDERSON
-
依托单位:
TESTING AND CALIBRATION OF SPECTROMETER FUNCTIONS
-
批准号:7954631
-
项目类别:
-
资助金额:$0.01万
-
财政年份:2009
-
负责人:MARK E ANDERSON
-
依托单位:
RUNNING POSSIBLE COLLABORATORY EXPERIMENTS
-
批准号:7954627
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2009
-
负责人:MARK E ANDERSON
-
依托单位:
CaMKII in Sinus Node Physiology and Disease
-
批准号:7891241
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:MARK E ANDERSON
-
依托单位:
海外基金